glp 1 and vertigo GLP-1 meds like semaglutide (Ozempic/Wegovy) tirzepatide (Mounjaro/Zepbound) have been game-changers for diabetes and weight loss — but a new study found they may also slightly increase the risk Navigating GLP-1 Side Effects: Understanding

At TIXiMED, we are excited to share new peer-reviewed data on #TIX100, published in Diabetes, Obesity and Metabolism by investigators at the UAB Comprehensive Diabetes Center

Get Started Today Important Information: All medications are compounded by FDA-registered 503A and 503B compounding pharmacies in accordance with applicable federal and state laws

Melanotan-1 is administered via subcutaneous injection into fatty tissue typically the abdomen, thigh, or upper arm using an insulin syringe (2931 gauge, 0.51mL capacity)

Consistent with other GLP-1 agonists, orforglipron labeling is expected to include the standard boxed warning about thyroid C-cell tumors and a contraindication in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

As per CNBC , list prices for Zepbound and Lillys diabetes treatment Mounjaro are both above US$1,000 a month, and uneven employer coverage has left roughly half of people with commercial insurance unable to start or stay on obesity treatment